These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34107188)

  • 1. Diffuse Large B-Cell Lymphoma.
    Lang R; Gill MJ
    N Engl J Med; 2021 Jun; 384(23):2261-2262. PubMed ID: 34107188
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous Presence of Follicular Lymphoma, Diffuse Large B-cell Lymphoma, and Hodgkin-like Lymphoma.
    Papoudou-Bai A; Marinos L; Papathanasiou K; Kanavaros P; Kapsali E
    Turk J Haematol; 2018 Nov; 35(4):308-309. PubMed ID: 30398157
    [No Abstract]   [Full Text] [Related]  

  • 3. Diffuse Large B-Cell Lymphoma. Reply.
    Sehn LH; Salles G
    N Engl J Med; 2021 Jun; 384(23):2262. PubMed ID: 34107189
    [No Abstract]   [Full Text] [Related]  

  • 4. IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children's Oncology Group trials.
    Chisholm KM; Mohlman J; Liew M; Termuhlen A; Cairo MS; Gross TG; Perkins SL; Miles RR
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27770. PubMed ID: 31012208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I study of ABT-199 (GDC-0199) in patients with relapsed/refractory non-Hodgkin lymphoma: responses observed in diffuse large B-cell (DLBCL) and follicular lymphoma (FL) at higher cohort doses.
    Clin Adv Hematol Oncol; 2014 Aug; 12(8 Suppl 16):18-9. PubMed ID: 25768998
    [No Abstract]   [Full Text] [Related]  

  • 6. Perfusion and flow extraction product as potential discriminators in untreated follicular and diffuse large B cell lymphomas using volume perfusion CT with attempt at histopathologic explanation.
    Spira D; Adam P; Linder C; Spira SM; Pintoffl J; Claussen CD; Horger M
    AJR Am J Roentgenol; 2012 Jun; 198(6):1239-46. PubMed ID: 22623535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.
    Borovecki A; Korać P; Nola M; Ivanković D; Jaksić B; Dominis M
    Croat Med J; 2008 Oct; 49(5):625-35. PubMed ID: 18925696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of follicular grade 3 non-Hodgkin's lymphoma.
    Bierman PJ
    Curr Opin Oncol; 2007 Sep; 19(5):433-7. PubMed ID: 17762566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma.
    Tilly H; Morschhauser F; Salles G; Casasnovas RO; Feugier P; Molina TJ; Jardin F; Terriou L; Haioun C; Coiffier B
    Leukemia; 2013 Jan; 27(1):252-5. PubMed ID: 22733106
    [No Abstract]   [Full Text] [Related]  

  • 10. [Occurrence of follicular small cleaved cell lymphoma following chemotherapy for diffuse large cell lymphoma].
    Saito S; Hayashi K; Ohnoshi T; Kawashima K; Matsutomo S; Tagawa S; Yoshino T; Nishiuchi R; Kimura I
    Rinsho Ketsueki; 1994 Jul; 35(7):676-81. PubMed ID: 8065020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment on "Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial".
    Vassilakopoulos TP; Apostolidis J; Angelopoulou MK
    Haematologica; 2015 Nov; 100(11):e480-1. PubMed ID: 26521298
    [No Abstract]   [Full Text] [Related]  

  • 12. Physical activity, obesity and survival in diffuse large B-cell and follicular lymphoma cases.
    Boyle T; Connors JM; Gascoyne RD; Berry BR; Sehn LH; Bashash M; Spinelli JJ
    Br J Haematol; 2017 Aug; 178(3):442-447. PubMed ID: 28466570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic burden and treatment patterns for patients with diffuse large B-cell lymphoma and follicular lymphoma in the USA.
    Ren J; Asche CV; Shou Y; Galaznik A
    J Comp Eff Res; 2019 Apr; 8(6):393-402. PubMed ID: 30855175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.
    Jaime-Pérez JC; Gamboa-Alonso CM; Vázquez-Mellado de Larracoechea A; Rodríguez-Martínez M; Gutiérrez-Aguirre CH; Marfil-Rivera LJ; Gómez-Almaguer D
    Arch Med Res; 2015 Aug; 46(6):454-61. PubMed ID: 26235285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to comment by P. Vassilakopoulos and colleagues.
    Jaeger U; Praxmarer M; Greil R;
    Haematologica; 2015 Nov; 100(11):e482. PubMed ID: 26521299
    [No Abstract]   [Full Text] [Related]  

  • 16. Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.
    Wendum D; Sebban C; Gaulard P; Coiffier B; Tilly H; Cazals D; Boehn A; Casasnovas RO; Bouabdallah R; Jaubert J; Ferrant A; Diebold J; de Mascarel A; Gisselbrecht C
    J Clin Oncol; 1997 Apr; 15(4):1654-63. PubMed ID: 9193366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD10 expression in follicular lymphoma and large cell lymphoma is different from that of reactive lymph node follicles.
    Almasri NM; Iturraspe JA; Braylan RC
    Arch Pathol Lab Med; 1998 Jun; 122(6):539-44. PubMed ID: 9625422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of Ibrutinib and ABT-199 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma.
    Kuo HP; Ezell SA; Schweighofer KJ; Cheung LWK; Hsieh S; Apatira M; Sirisawad M; Eckert K; Hsu SJ; Chen CT; Beaupre DM; Versele M; Chang BY
    Mol Cancer Ther; 2017 Jul; 16(7):1246-1256. PubMed ID: 28428442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival outcomes of diffuse large B-cell lymphoma by association with concurrent or antecedent follicular lymphoma and double hit status.
    Behdad A; Boddy CS; Fought AJ; Taxter T; Falkiewicz MK; Ayers E; Chen QC; Chen YH; Karmali R; Pro B; Winter JN; Landsburg DJ; Gordon LI; Kaplan JB
    Leuk Lymphoma; 2019 Dec; 60(13):3266-3271. PubMed ID: 31225766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous B-cell lymphomas: part II. Therapy and future directions.
    Suárez AL; Querfeld C; Horwitz S; Pulitzer M; Moskowitz A; Myskowski PL
    J Am Acad Dermatol; 2013 Sep; 69(3):343.e1-11; quiz 355-6. PubMed ID: 23957985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.